-
公开(公告)号:EP1320548A2
公开(公告)日:2003-06-25
申请号:EP01939490.7
申请日:2001-05-25
发明人: THORNTON, Michael , CHAWLA, Narinder, K , YUE, Henry , NGUYEN, Danniel, B , LAI, Preeti , GANDHI, Ameena, R , TRIBOULEY, Catherine, M , YAO, Monique, G , RAMKUMAR, Jayalaxmi , AU-YOUNG, Janice , LU, Yan , TANG, Y., Tom , AZIMZAI, Yalda , BRUNS, Christopher M., , GRIFFIN, Jennifer, A , YANG, Junming , SANJANWALA, Madhu, S , RAUMANN, Brigitte, E , LEE, Ernestine, A , HAFALIA, April , BAUGHN, Mariah, R , GREEN, Barrie, D , KHAN, Farrah, A , KEARNEY, Liam , ELLIOT, Vicki, S , SEILHAMER, Jeffrey, J , POLICKY, Jennifer, L , BOROWSKY, Mark, L , BURFORD, Neil , DING, Li , LU, Dyung, Aina, M , JACKSON, Jennifer, L
IPC分类号: C07K14/705
CPC分类号: C07K14/47
摘要: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
-
公开(公告)号:EP1387886A2
公开(公告)日:2004-02-11
申请号:EP01987550.9
申请日:2001-10-18
发明人: LEE, Ernestine, A. , HAFALIA, April, J.A. , YUE, Henry , LAL, Preeti, G , YAO, Monique, G , LU, Yan , CHAWLA, Narinder, K. , WARREN, Bridget, A. , LU, Dyung, Aina, M. , BAUGHN, Mariah, R. , DELEGEANE, Angelo, M. , BURFORD, Neil , BOROWSKY, Mark, L. , LEE, Sally , XU, Yuming , GRIFFIN, Jennifer, A. , KALLICK, Deborah, A. , GANDHI, Ameena, R. , ARVIZU, Chandra S. , ISON, Craig H. , TANG, Y. Tom , AZIMZAI, Yalda , ELLIOTT, Vicki S. , SWARNAKAR, Anita , RAMKUMAR, Jayalaxmi , NGUYEN, Danniel B. , TRIBOULEY, Catherine M. , LO, Terence P. , AU-YOUNG, Janice , THANGAVELU, Kavitha , KEARNEY, Liam
IPC分类号: C12N9/64
CPC分类号: C12N9/6421
摘要: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
-
公开(公告)号:EP1299545A2
公开(公告)日:2003-04-09
申请号:EP01948877.4
申请日:2001-07-05
发明人: BAUGHN, Mariah, R. , BRUNS, Christopher, M. , DAS, Debopriya , DING, Li , ELLIOTT, Vicki, S. , GANDHI, Ameena, R. , HAFALIA, April, J., A. , KEARNEY, Liam , KHAN, Farrah, A. , LAL, Preeti , LEE, Ernestine, A. , LU, Dyung, Aina, M. , LU, Yan , NGUYEN, Danniel, B. , PATTERSON, Chandra , RAMKUMAR, Jayalaxmi , RING, Huijun, Z. , SANJANWALA, Madhu, S. , TANG, Y., Tom , THORNTON, Michael , TRIBOULEY, Catherine, M. , THORNTON, Michael , WALIA, Narinder, K , XU, Yuming , YANG, Jumming , YAO, Monique, G , YUE, Henry
IPC分类号: C12N15/52 , C12N9/00 , C12N5/10 , A01K67/027 , C07K16/40 , C12Q1/68 , G01N33/573
摘要: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
-
公开(公告)号:EP1290187A2
公开(公告)日:2003-03-12
申请号:EP01946479.1
申请日:2001-06-14
发明人: YUE, Henry , LAL, Preeti , BANDMAN, Olga , BOROWSKY, Mark,L , AU-YOUNG, Janice , LU, Yan , GANDHI, Ammena, R , TRIBOULEY, Catherine, M , WALIA, Narinder,K , YAO, Monique, G , LU,Dyung, Aina,M , GREENWALD,Sara, R , RAMKUMAR,Jayalaxmi , GRIFFIN,Jennifer, A , KEARNEY, Liam , BURFORD, Neil , NGUYEN, Danniel, B , TANG,Y Tom , BAUGHN, Mariah, R , HE, Ann , THORNTON, Michael , HAFALIA, April , PATTERSON, Chandra , GURURAJAN,Rajagopal , LO, Terence, P , KHAN, Farrah , RECIPON, Shirley, A , AZIMZAI, Yalda , POLICKY, Jennifer, L , DING,Li , GRETHER, Megan , ELLIOTT, Vicki, S , THANGAVELU, Kavitha , BATRA, Sajeev , ISON, Craig, H
IPC分类号: C12N15/54 , C12N9/12 , C07K16/40 , C12Q1/68 , G01N33/573
CPC分类号: C12N9/12
摘要: The invention provides human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or prevention disorders associated with aberrant expression of PKIN.
-
-
-